YZYanyan Zhu

Yanyan Zhu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yanyan Zhu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Bowang Chen

    Department of Oncology, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou, China

    2 shared publications
  • Junya Yan

    Department of Oncology, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou, China

    2 shared publications
  • Na Sun

    Department of Oncology, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou, China

    2 shared publications
  • Pengli Dou

    Department of Oncology, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou, China

    2 shared publications
  • Wendi Zhao

    Department of Oncology, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou, China

    2 shared publications
  • Xiaoyun Huang

    JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China

    2 shared publications

Latest Publications

  • Open Access

    BNIP3 Upregulation Characterizes Cancer Cell Subpopulation With Increased Fitness and Proliferation

    by Yanyan Zhu, Bowang Chen, Junya Yan, Wendi Zhao, Pengli Dou, Na Sun, Yaokai Wang, Xiaoyun Huang

    BNIP3 is a BH3-only protein with both pro-apoptotic and pro-survival roles depending on the cellular context. It remains unclear how BNIP3 RNA level dictates cell fate decisions of cancer cells. Here, we undertook a quantitative analysis of BNIP3 expression and functions in single-cell datasets of various epithelial malignancies. Our results demonstrated that BNIP3 upregulation characterizes cancer cell subpopulations with increased fitness and proliferation. We further validated the upregulation of BNIP3 in liver cancer 3D organoid cultures compared with 2D culture. Taken together, the combination of in silico perturbations using public single-cell datasets and experimental cancer modeling using organoids ushered in a new approach to address cancer heterogeneity.


  • Open Access

    BNIP3 upregulation characterizes cancer cell subpopulation with increased fitness and proliferation

    by Yanyan Zhu, Bowang Chen, Junya Yan, Wendi Zhao, Pengli Dou, Na Sun, Yaokai Wang, Xiaoyun Huang

    BNIP3 is a BH3 only protein with both pro-apoptotic and pro-survival roles depending on the cellular context. It remains unclear how BNIP3 RNA level dictates cell fate decisions of cancer cells. Here we undertook a quantitative analysis of BNIP3 expression and functions in single cell datasets of various epithelial malignancies. Our results demonstrated that BNIP3 upregulation characterizes cancer cell subpopulations with increased fitness and proliferation. We further validated the upregulation of BNIP3 in liver cancer organoids compared with 2D culture. Taken together, the combination of in silico perturbations using public single cell datasets and experimental cancer modeling using organoids ushered in a new approach to address cancer heterogeneity.